Obstetrics & Gynecology Doctors in Fort Bragg, NC Accepting Medicare

5 Obstetrics & Gynecology doctors found. Showing 1 - 5

Dr. Archie Dean Kesler Jr., MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2817 Reilly Rd Ob Gyn Clinic, Womack Army Medical Center, Fort Bragg, NC 28310 Phone: 910-907-6881

Dr. Rodney Allen Sr., M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2817 Reilly Rd, Dept. Of Ob/gyn, Fort Bragg, NC 28310 Phone: 910-907-6250

Karen Wilson, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: Womack Ob Gyn Clinic Bldg 4, 2817 Reilly Road, Fort Bragg, NC 28310 Phone: 910-907-8471    Fax: 910-908-7379

Colleen Ezzell, Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2817 Reilly St, Fort Bragg, NC 28310 Phone: 910-907-6000

Dr. Natasha Gouey, DO Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: Womack Army Medical Center 2817 Reilly Rd, Fort Bragg, NC 28310 Phone: 910-907-6670

News Archive

Study: A record number of elderly people are completing living wills to guide end-of-life medical treatments

A record number of elderly people are completing living wills to guide end-of-life medical treatments - up from 47 percent in 2000 to 72 percent in 2010 - according to new research from the University of Michigan and the Veterans Affairs Ann Arbor Healthcare System.

FDA approves DNA test to measure hepatitis B viral load

The U.S. Food and Drug Administration today approved the first nucleic acid test for hepatitis B virus (HBV) that measures the amount of viral DNA (viral load) in a patient's blood. Assessing a patient's viral load provides health care professionals with a highly sensitive method for gauging the progress of antiviral therapy in patients with chronic HBV infections.

Therakos commences enrollment in photopheresis Phase IIb clinical study for chronic GvHD

Therakos, Inc., a pioneer in the innovative treatment of extracorporeal photopheresis (ECP) for immune modulation therapy, today announced that the first patient has been enrolled in its Phase IIb clinical study evaluating the use of the company's photopheresis technology in the treatment of patients with moderate-to-severe chronic Graft-versus-Host Disease (GvHD).

Research roundup: Insurance coverage and access to care in Massachusetts

With increasing interest in public health problems such as obesity and alcohol and tobacco use, lawmakers are increasingly considering using policy to modify behavior. According to the authors, little is currently known about the public's willingness to accept such policies.

Read more Medical News

› Verified 1 days ago